| | | | | | | | Facing a daunting landscape, pharma companies are enlisting the help of focused contract manufacturers to shape their therapies from the ground up. CDMOs, who so often go unnamed and unsung, have now become integral to forging the future of pharma. |
|
|
|
| |
| | |
|
|
| | | | | Gepotidacin, a potential first-in-class oral antibiotic, is already armed with two positive trials in UTIs. |
|
|
| The drugmaker shared that the trials demonstrated a reduction of up to 63% in the apnea-hypopnea index. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome the challenges to de-risk & optimize the path to manufacturing success. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
